Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of omeprazole intake on faecal calprotectin
2015-003903-51Phase 3Completed
- Sponsor
- Linköping University
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of omeprazole in inflammatory bowel disease (IBD) (2 arms), sponsored by Linköping University. Primary endpoint: Change in faecal calprotectin level. Started Sep 2016; status: completed.
02
Drugs
omeprazole
03
Conditions
inflammatory bowel disease (IBD)
Beyond the preview
Go deeper on 2015-003903-51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003903-51.